A critical discovery in cancer research is emerging with the use of VHH fragments to reactivate damaged p53. This essential tumor inhibitor protein is frequently disabled in various kinds of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research